“IDT is progressing discussions to put forward its cGMP manufacturing facilities
and capabilities to get behind the Victorian Government’s landmark commitment
and initiative to develop an mRNA manufacturing capability, as we believe it will
build upon the existing scientific and medical strengths in Victoria and will deliver
essential capabilities for Australia.” said Dr David Sparling, CEO of IDT Australia
Limited. “Manufacturing clinic-ready vaccine candidates coming out of world class
mRNA, so Moderna back again?
Ann: COVID-19 Vaccine Manufacture discussions with VicGov & MIPS, page-2
Add IDT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $34.09M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.7¢ | $43.65K | 440.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10055 | 9.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 1156695 | 1 |
View Market Depth
| Last trade - 15.59pm 22/05/2024 (20 minute delay) ? |
|
|||||
|
Last
9.7¢ |
Change
0.000 ( 6.64 %) |
||||
| Open | High | Low | Volume | ||
| 10.0¢ | 10.0¢ | 9.7¢ | 129350 | ||
| Last updated 15.43pm 22/05/2024 ? | |||||
| IDT (ASX) Chart |